Загрузка...
165 Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist in Patients With Hereditary Angioedema due to C1-INH Deficiency
BACKGROUND: To compare the efficacy of icatibant in early versus late treated attacks of hereditary angioedema. METHODS: Thirty-one patients received 30 mg icatibant subcutaneously at various times for 121 swelling attacks. The time periods between onset of attacks and icatibant injection, icatibant...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
World Allergy Organization Journal
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513132/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000411922.50578.13 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|